Scilex Holding Price Target Maintained With a $7.00/Share by HC Wainwright & Co.
Alliance Global Partners Initiates Coverage On Scilex Holding With Buy Rating, Announces Price Target of $14
Scilex Holding Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Scilex Holding, Maintains $7 Price Target
Scilex Holding Analyst Ratings
Rodman & Renshaw Initiates Coverage On Scilex Holding With Buy Rating, Announces Price Target of $13
Scilex Holding Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Scilex Holding, Maintains $7 Price Target
Scilex Holding Analyst Ratings
HC Wainwright & Co. : The Scilex Holding (SCLX.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $12.00 to $8.00.
Scilex Holding Analyst Ratings
HC Wainwright & Co. Maintains Buy on Scilex Holding, Lowers Price Target to $8
Buy Rating Affirmed for Scilex Holding Amid Strong Product Performance and Improved Financial Outlook
Analysts Offer Insights on Healthcare Companies: Spruce Biosciences (SPRB) and Scilex Holding Company (SCLX)
HC Wainwright & Co. Reiterates Buy on Scilex Holding, Maintains $12 Price Target
Scilex Holding Analyst Ratings
Strategic Advancements and Financial Growth Affirm Buy Rating for Scilex Holding Company
Scilex Holding Company's Strong Portfolio and Positive Operational Execution: A Buy Recommendation
Analysts' Top Consumer Goods Picks: Scilex Holding Company (SCLX), Walmart (WMT)
B. Riley Securities Initiates Coverage On Scilex Holding With Buy Rating, Announces Price Target of $4